cataract
CATARACT
Cataract is the presence of opacity in the crystalline lens of the eye. It causes painless, progressive blurring of vision.
It is the leading cause of blindness worldwide and the most prevalent ocular disease.
The initiating events that lead to loss of transparency of both the cortical and nuclear lens tissue is the oxidation of the membrane lipids, structural or enzymatic proteins or DNA by peroxidases or free radicals induced by UV light.

Introduction

  • Cataract is the presence of opacity in the crystalline lens that causes painless, progressive blurring of vision
  • Leading cause of blindness worldwide & the most prevalent ocular disease
  • Mechanism of cataract formation is multifactorial
  • Chronic & age-related

Signs and Symptoms

  • Decreased vision & increased problems w/ glare are the hallmark symptoms
  • Increased nearsightedness called “myopic shift “before opacity of the lens occur
  • Typically bilateral but often asymmetrical

Etiology

  • Initiating events that lead to loss of transparency of both the cortical & nuclear lens tissue is the oxidation of the membrane lipids, structural or enzymatic proteins or DNA by peroxidases or free radicals induced by ultraviolet (UV) light

Risk Factors

  • Increasing age
  • Ultraviolet (UV) radiation - ultraviolet B (UVB) cumulative lifetime exposure
  • Diabetes mellitus, hypertension, high body mass index
  • Drugs (eg long-term topical, systemic or inhaled corticosteroids, Phenothiazine, Chlorpromazine)
  • Smoking
  • Drinking excessive amounts of alcohol
  • Gender - females are most likely to have cataract & progress to blindness
  • Nutrition - low antioxidant levels is associated w/ increased risk of cataract formation
  • Obesity
  • Dehydration/diarrheal crises
  • Genetics in age-related cataract cases (eg cortical cataracts & nuclear cataracts)
  • Prior intraocular surgery
  • Moderate to high myopia
  • Exposure to ionizing radiation (eg chest x-ray, radiation therapy)
Editor's Recommendations
Most Read Articles
27 Apr 2017
The baseline inferior subfield retinal thickness may predict the frequency of treatment for diabetic macular oedema (DME) during the first year in eyes administered pro re nata (PRN) intravitreal ranibizumab (IVR) injections, a new study shows.